Dr. Frank Ong is the Chief Medical and Scientific Officer at EverlyWell, the digital health company poised to disrupt the 25 billion dollar diagnostics industry by providing consumers with at-home lab testing kits that include insightful, easy-to-understand results. Dr. Ong leads the company's medical affairs including clinical laboratory operations, research, and clinical development including new test development.
Prior to joining EverlyWell, Dr. Ong held leadership positions at Guardant Health, Roche Diagnostics, and Illumina and served as a faculty member and researcher at Cedars-Sinai Medical Center, where he received research grants from the National Institutes of Health (NIH). He earned his medical degree from the Keck School of Medicine at the University of Southern California and holds graduate certificates in clinical and translational investigation, biodesign and medical device innovation and clinical trial administration from Stanford University, UCLA and University of California San Diego. He served his residency in the Department of Family Medicine at UCLA's Geffen School of Medicine. He resides in Austin, Texas.
Walter is a laboratory management and operations professional with experience in a number of laboratory specialties including molecular diagnostics, infectious disease, immunology, chemistry, toxicology, histology and hematology. He graduated from Auburn University with a degree in Cellular, Molecular and Microbiology and is an ASCP board-certified Molecular Biologist. Walter has started, operationalized and obtained certification and accreditation for a number of reference and hospital-based laboratories throughout his career. He serves on EverlyWell's leadership team as the Director of Laboratory Operations and manages laboratory partnerships and ensures testing quality and compliance.